Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124887533 | 12488753 | 3 | F | 20150203 | 20160902 | 20160622 | 20160908 | EXP | JP-PFIZER INC-2016306348 | PFIZER | 54.00 | YR | F | Y | 36.00000 | KG | 20160908 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124887533 | 12488753 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | 8000 | MG | Y | 20753 | 25 | MG | COATED TABLET | QD | |||
| 124887533 | 12488753 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | 8000 | MG | Y | 20753 | 25 | MG | COATED TABLET | QD | |||
| 124887533 | 12488753 | 3 | SS | AZULFIDINE EN-TABS | SULFASALAZINE | 1 | Oral | 500 MG, 2X/DAY | 452000 | MG | Y | 7073 | 500 | MG | MODIFIED-RELEASE TABLET | BID | |||
| 124887533 | 12488753 | 4 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, 1X/DAY | 1312 | MG | Y | 0 | 10 | MG | TABLET | QD | |||
| 124887533 | 12488753 | 5 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 7.5 MG, 1X/DAY | 1312 | MG | Y | 0 | 7.5 | MG | TABLET | QD | |||
| 124887533 | 12488753 | 6 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 2.5 MG, 1X/DAY | 1312 | MG | Y | 0 | 2.5 | MG | TABLET | QD | |||
| 124887533 | 12488753 | 7 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, 1X/DAY | 1312 | MG | Y | 0 | 5 | MG | TABLET | QD | |||
| 124887533 | 12488753 | 8 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, 1X/DAY | 1312 | MG | Y | 0 | 5 | MG | TABLET | QD | |||
| 124887533 | 12488753 | 9 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 7.5 MG, 1X/DAY | 1312 | MG | Y | 0 | 7.5 | MG | TABLET | QD | |||
| 124887533 | 12488753 | 10 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, 1X/DAY | 1312 | MG | Y | 0 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124887533 | 12488753 | 1 | Breast cancer metastatic |
| 124887533 | 12488753 | 3 | Rheumatoid arthritis |
| 124887533 | 12488753 | 4 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124887533 | 12488753 | OT |
| 124887533 | 12488753 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124887533 | 12488753 | Interstitial lung disease | |
| 124887533 | 12488753 | Pneumonia bacterial | |
| 124887533 | 12488753 | Rheumatoid arthritis | |
| 124887533 | 12488753 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124887533 | 12488753 | 1 | 20140426 | 20150311 | 0 | |
| 124887533 | 12488753 | 2 | 20160412 | 0 | ||
| 124887533 | 12488753 | 3 | 20150324 | 20160617 | 0 | |
| 124887533 | 12488753 | 4 | 20140412 | 0 | ||
| 124887533 | 12488753 | 5 | 20140524 | 20140606 | 0 | |
| 124887533 | 12488753 | 6 | 20140627 | 0 | ||
| 124887533 | 12488753 | 7 | 20140718 | 20150227 | 0 | |
| 124887533 | 12488753 | 8 | 20150311 | 0 | ||
| 124887533 | 12488753 | 9 | 20160607 | 20160617 | 0 | |
| 124887533 | 12488753 | 10 | 20160715 | 0 |